Two Sigma Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.4M Sell
483,098
-333,558
-41% -$7.19M 0.02% 782
2025
Q1
$13.6M Sell
816,656
-426,786
-34% -$7.09M 0.03% 624
2024
Q4
$22.8M Buy
1,243,442
+133,186
+12% +$2.44M 0.05% 413
2024
Q3
$17.1M Buy
1,110,256
+762,539
+219% +$11.7M 0.04% 521
2024
Q2
$5.65M Buy
347,717
+238,288
+218% +$3.87M 0.01% 900
2024
Q1
$2.02M Sell
109,429
-239,299
-69% -$4.42M ﹤0.01% 1413
2023
Q4
$10.9M Buy
348,728
+278,628
+397% +$8.72M 0.03% 599
2023
Q3
$1.46M Sell
70,100
-296,688
-81% -$6.18M ﹤0.01% 1618
2023
Q2
$8.78M Buy
366,788
+260,588
+245% +$6.24M 0.02% 651
2023
Q1
$2M Buy
106,200
+95,063
+854% +$1.79M 0.01% 1317
2022
Q4
$177K Buy
+11,137
New +$177K ﹤0.01% 2357
2022
Q3
Sell
-58,800
Closed -$828K 2387
2022
Q2
$828K Sell
58,800
-181,671
-76% -$2.56M ﹤0.01% 1569
2022
Q1
$5.82M Buy
240,471
+214,371
+821% +$5.19M 0.02% 834
2021
Q4
$609K Buy
26,100
+10,400
+66% +$243K ﹤0.01% 1894
2021
Q3
$261K Buy
15,700
+1,900
+14% +$31.6K ﹤0.01% 2234
2021
Q2
$337K Buy
+13,800
New +$337K ﹤0.01% 2090
2020
Q3
Sell
-286,618
Closed -$13.9M 1830
2020
Q2
$13.9M Buy
+286,618
New +$13.9M 0.07% 268
2020
Q1
Sell
-71,480
Closed -$3.06M 1845
2019
Q4
$3.06M Sell
71,480
-138,016
-66% -$5.9M 0.01% 929
2019
Q3
$7.54M Buy
209,496
+10,873
+5% +$391K 0.03% 522
2019
Q2
$5.31M Buy
+198,623
New +$5.31M 0.02% 702
2017
Q1
Sell
-49,639
Closed -$1.43M 2078
2016
Q4
$1.43M Buy
+49,639
New +$1.43M 0.01% 1318